Cardinal Health's Volume Slides to 439th as Stock Dips 0.35% Amid Supply Chain Probes and Partnership Exit

On October 9, 2025, Cardinal Health (CAH) traded with a volume of $0.25 billion, ranking 439th in market activity. The stock closed down 0.35% for the session amid mixed market conditions.

Recent developments highlight potential operational challenges for the healthcare services provider. A regulatory filing revealed ongoing internal investigations into supply chain management practices, raising concerns about compliance risks. Separately, a partnership agreement with a regional pharmaceutical distributor was terminated unexpectedly, though no financial penalties were disclosed. Both factors contributed to cautious investor sentiment despite the company's recent earnings beat in Q3.

Market participants noted the stock's underperformance relative to peers, with analysts attributing the divergence to uncertainty surrounding the company's long-term strategic direction. Short-term technical indicators remain bearish, with key support levels now tested following a consolidation phase that began in early September.

To run this back-test accurately I need to clarify a couple of points and confirm that the set-up matches what you have in mind: 1. Universe • Which exchange(s) should be included when we rank stocks by volume? (e.g., all U.S. common stocks on NYSE + NASDAQ, or another market universe). 2. Weighting & rebalancing details • Do you want the 500 selected names each day to be held in an equal-weight portfolio, or some other weighting (e.g., volume-weighted, market-cap-weighted)? • Should the portfolio be rebalanced every trading day so that at the next close we sell everything and buy the new top-500 list? 3. Execution price • Assume we buy at the close of day t (after the volume ranking is known) and sell at the close of day t+1? • Or buy at next day’s open and sell at next day’s close? 4. Slippage / transaction costs • Should we include any commission or slippage assumptions, or ignore trading costs? 5. Technical constraint • The current back-test engine in this environment evaluates one ticker at a time. To implement a 500-stock daily-rebalanced portfolio I’ll need to run a custom multi-asset workflow (which is feasible, but requires the above details). Please let me know your preferences on these items, and I’ll proceed with the appropriate data retrieval and back-testing steps.